Incidence and Prognostic Implication of Acute CV Events in Patients Hospitalized for CAP in Internal Medicine Units.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1266 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-10-01

Study Completion Date

2018-03-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

FADOI-ICECAP is a observational, prospective, multicenter study involving 20-25 nationwide Units of Internal Medicine. The study foresees the participation of 26 Internal Medicine Operative Units, and for each of them a prospective registration of data relative to at least 50 patients admitted with CAP (in total, at least 1300 evaluable subjects) is foreseen.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Assessment of Functional Capacity and Inflammatory Markers in Women With Heart Failure With Preserved Ejection Fraction

NCT02649400

Heart Failure, Diastolic Coronary Artery Disease Inflammation

UNKNOWN

Probiotics and Inflammatory Status in Patients With Heart Failure

NCT03968549

Heart Failure

UNKNOWN NA

The Role of the Pulmonary Vasculature in the Fontan Circulation

NCT02414321

Congenital Heart Disease Fontan Operation Pulmonary Vascular Resistance +1 more

RECRUITING

Peripheral Artery Occlusive Disease (PAOD) in Women Hospitalized for Type 1 Myocardial Infarction in Intensive Cardiology Care

NCT05149456

PAOD - Peripheral Arterial Occlusive Disease

UNKNOWN

Adipose Tissue and Inflammation in Coronary Heart Disease

NCT02760914

Coronary Heart Disease

ACTIVE_NOT_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Phase 1 - Patients enrollment (October 2016 - February 2018) Each Investigator have recorded data concerning 50 patients. It will be collected general characteristics of patients, clinical parameters and conditions, diagnostic imaging and blood tests,

Phase 2 - Database review and validation (April 2018 - October 2018) The data collected will be analysed to process the endpoints.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiovascular Events

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with CAP hospitalized in IM

Data of Patients with Community-acquired pneumonia (CAP) hospitalized in Internal Medicine Units will be collected for this study; no intervention is planned for this study

No intervention

Intervention Type OTHER

In this study there is no intervention

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention

In this study there is no intervention

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age \> 18 years
2. Diagnosis of pneumonia defined by the presence on chest X-ray or CT-scan of lung of new infiltration associated with at least two of the following clinical features:

* fever \> 37.8°C
* typical symptoms (dyspnea, productive cough, pain)
* typical clinical signs on chest examination (crepitation, bronchial breathing, pleural effusion)
* leukocytosis

Exclusion Criteria

* patients with Hospital-Acquired Pneumonia (HAP) (i.e. those patients with pneumonia acquired in hospital more than 48 hours after admission)
* patients with tuberculosis in active phase
* patients with cystic fibrosis
* patients who refuse to participate in the study and/or to give the written informed consent.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No